Welcome to LookChem.com Sign In|Join Free
  • or
(R,E)-methyl 2-(3-(acetylthio)-3-(3-(2-(7-chloroquinolin-2-yl)vinyl)phenyl)propyl)benzoate is a complex organic compound that serves as a reagent in the synthesis of Montelukast Sodium Salt (M568000), a pharmaceutical agent with significant therapeutic applications.
Used in Pharmaceutical Industry:
(R,E)-methyl 2-(3-(acetylthio)-3-(3-(2-(7-chloroquinolin-2-yl)vinyl)phenyl)propyl)benzoate is used as a reagent for the preparation of Montelukast Sodium Salt, which is a selective leukotriene D4-receptor antagonist. This makes it instrumental in the development of antiasthmatic medications, providing a targeted approach to treating asthma and other respiratory conditions by blocking the action of leukotrienes, which are inflammatory mediators.

855473-48-2

Post Buying Request

855473-48-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

855473-48-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 855473-48-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,5,4,7 and 3 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 855473-48:
(8*8)+(7*5)+(6*5)+(5*4)+(4*7)+(3*3)+(2*4)+(1*8)=202
202 % 10 = 2
So 855473-48-2 is a valid CAS Registry Number.

855473-48-2Relevant academic research and scientific papers

Efficient synthesis for the preparation of montelukast

-

Page/Page column 9, (2011/04/14)

The present invention describes the improved process for the preparation of montelukast acid and its pharmaceutically acceptable salts and esters. The process is cost effective, environment friendly, and easily scale up to commercial level.

EFFICIENT SYNTHESIS FOR THE PREPARATION OF MONTELUKAST AND NOVEL CRYSTALLINE FORM OF INTERMEDIATES THEREIN

-

Page/Page column 30; 31, (2011/10/13)

The present invention describes the improved process for the preparation of montelukast acid (VII) and its pharmaceutically acceptable salts and esters using a novel synthesis step. The process is cost effective, environment friendly, and easily scale up to commercial level and leads to products having high chemical and optical purity. Moreover, the present invention provides a novel crystalline intermediate (IV) that is useful in this process and a method for its production. In a further aspect, the process of the present invention includes a step of removing ketone by-products be derivatization.

PROCESS FOR MAKING MONTELUKAST AND INTERMEDIATES THEREFOR

-

Page/Page column 29, (2008/06/13)

A process for making montelukast, a pharmaceutically useful compound of the following formula and salts thereof: (1) using a compound of formula (11) is provided.

Process for making montelukast and intermediates therefor

-

Page/Page column 12, (2008/06/13)

A process for making montelukast, a pharmaceutically useful compound of the following formula and salts thereof: using a compound of formula (20) is provided.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 855473-48-2